Anantin
| Internal ID | add08f03-0e49-4035-8631-a986bdd76a56 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Hybrid peptides |
| IUPAC Name | (3R)-3-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S,3R)-2-[[(5S,8R,14R,20R,23S)-20-(2-amino-2-oxoethyl)-5-benzyl-8-[(2S)-butan-2-yl]-14-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,25-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacosane-23-carbonyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-4-[[(1R)-1-carboxy-2-phenylethyl]amino]-4-oxobutanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C90H111N21O24/c1-5-48(3)77-88(132)98-45-75(120)101-62(34-54-39-93-58-25-17-16-24-57(54)58)80(124)96-43-73(118)103-64(36-69(91)114)84(128)106-65(37-70(115)94-41-71(116)100-60(86(130)110-77)31-51-20-12-8-13-21-51)87(131)111-78(49(4)6-2)89(133)107-59(30-50-18-10-7-11-19-50)79(123)95-42-72(117)102-63(35-55-40-92-47-99-55)83(127)105-61(32-53-26-28-56(113)29-27-53)82(126)109-68(46-112)81(125)97-44-74(119)104-66(38-76(121)122)85(129)108-67(90(134)135)33-52-22-14-9-15-23-52/h7-29,39-40,47-49,59-68,77-78,93,112-113H,5-6,30-38,41-46H2,1-4H3,(H2,91,114)(H,92,99)(H,94,115)(H,95,123)(H,96,124)(H,97,125)(H,98,132)(H,100,116)(H,101,120)(H,102,117)(H,103,118)(H,104,119)(H,105,127)(H,106,128)(H,107,133)(H,108,129)(H,109,126)(H,110,130)(H,111,131)(H,121,122)(H,134,135)/t48-,49+,59-,60-,61-,62+,63-,64+,65-,66+,67+,68-,77+,78-/m0/s1 |
| InChI Key | PXMKNCAIFBQHPS-XPZIXDMWSA-N |
| Popularity | 21 references in papers |
| Molecular Formula | C90H111N21O24 |
| Molecular Weight | 1871.00 g/mol |
| Exact Mass | 1869.81108349 g/mol |
| Topological Polar Surface Area (TPSA) | 697.00 Ų |
| XlogP | -0.50 |
| Atomic LogP (AlogP) | -5.33 |
| H-Bond Acceptor | 23 |
| H-Bond Donor | 24 |
| Rotatable Bonds | 40 |
| RefChem:915797 |
| (3R)-3-((2-(((2S)-2-(((2S)-2-(((2S)-2-((2-(((2S)-2-(((2S,3R)-2-(((5S,8R,14R,20R,23S)-20-(2-amino-2-oxoethyl)-5-benzyl-8-((2S)-butan-2-yl)-14-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,25-octaoxo-1,4,7,10,13,16,19,22-octazacyclopentacosane-23-carbonyl)amino)-3-methylpentanoyl)amino)-3-phenylpropanoyl)amino)acetyl)amino)-3-(1H-imidazol-5-yl)propanoyl)amino)-3-(4-hydroxyphenyl)propanoyl)amino)-3-hydroxypropanoyl)amino)acetyl)amino)-4-(((1R)-1-carboxy-2-phenylethyl)amino)-4-oxobutanoic acid |
| 133658-45-4 |
| CHEBI:221528 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9642 | 96.42% |
| Caco-2 | - | 0.8658 | 86.58% |
| Blood Brain Barrier | - | 0.9000 | 90.00% |
| Human oral bioavailability | - | 0.6429 | 64.29% |
| Subcellular localzation | Mitochondria | 0.3961 | 39.61% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.7986 | 79.86% |
| OATP1B3 inhibitior | + | 0.9386 | 93.86% |
| MATE1 inhibitior | - | 0.9209 | 92.09% |
| OCT2 inhibitior | - | 0.8250 | 82.50% |
| BSEP inhibitior | + | 0.9691 | 96.91% |
| P-glycoprotein inhibitior | + | 0.7419 | 74.19% |
| P-glycoprotein substrate | + | 0.8672 | 86.72% |
| CYP3A4 substrate | + | 0.7533 | 75.33% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8597 | 85.97% |
| CYP3A4 inhibition | - | 0.8542 | 85.42% |
| CYP2C9 inhibition | - | 0.8753 | 87.53% |
| CYP2C19 inhibition | - | 0.8339 | 83.39% |
| CYP2D6 inhibition | - | 0.8864 | 88.64% |
| CYP1A2 inhibition | - | 0.8517 | 85.17% |
| CYP2C8 inhibition | + | 0.8439 | 84.39% |
| CYP inhibitory promiscuity | - | 0.8146 | 81.46% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8000 | 80.00% |
| Carcinogenicity (trinary) | Non-required | 0.5833 | 58.33% |
| Eye corrosion | - | 0.9893 | 98.93% |
| Eye irritation | - | 0.8954 | 89.54% |
| Skin irritation | - | 0.7982 | 79.82% |
| Skin corrosion | - | 0.9397 | 93.97% |
| Ames mutagenesis | - | 0.7300 | 73.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7224 | 72.24% |
| Micronuclear | + | 0.8200 | 82.00% |
| Hepatotoxicity | - | 0.5467 | 54.67% |
| skin sensitisation | - | 0.8849 | 88.49% |
| Respiratory toxicity | + | 0.8222 | 82.22% |
| Reproductive toxicity | + | 0.9373 | 93.73% |
| Mitochondrial toxicity | + | 0.8125 | 81.25% |
| Nephrotoxicity | + | 0.5759 | 57.59% |
| Acute Oral Toxicity (c) | III | 0.5661 | 56.61% |
| Estrogen receptor binding | - | 0.5529 | 55.29% |
| Androgen receptor binding | + | 0.7475 | 74.75% |
| Thyroid receptor binding | + | 0.7981 | 79.81% |
| Glucocorticoid receptor binding | + | 0.8344 | 83.44% |
| Aromatase binding | + | 0.8128 | 81.28% |
| PPAR gamma | + | 0.7466 | 74.66% |
| Honey bee toxicity | - | 0.6380 | 63.80% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.6800 | 68.00% |
| Fish aquatic toxicity | + | 0.7841 | 78.41% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.98% | 98.95% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.91% | 83.82% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.65% | 91.11% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 99.59% | 97.23% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 99.35% | 90.20% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 99.33% | 97.64% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.87% | 96.09% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 98.40% | 88.42% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 96.93% | 88.56% |
| CHEMBL2535 | P11166 | Glucose transporter | 96.67% | 98.75% |
| CHEMBL236 | P41143 | Delta opioid receptor | 96.53% | 99.35% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 96.29% | 90.17% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.07% | 94.45% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 95.64% | 90.08% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 94.70% | 95.50% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 94.33% | 95.56% |
| CHEMBL5896 | O75164 | Lysine-specific demethylase 4A | 94.10% | 99.09% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 93.67% | 98.59% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 93.67% | 91.71% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 93.16% | 97.09% |
| CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 92.81% | 99.15% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 92.07% | 96.90% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 91.79% | 99.17% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 91.69% | 83.10% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 91.34% | 89.33% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 90.25% | 98.94% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 90.14% | 89.00% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 89.74% | 95.38% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 89.09% | 82.86% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 89.01% | 99.23% |
| CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 | 88.88% | 94.62% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 88.47% | 85.14% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 87.93% | 96.67% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 87.63% | 97.14% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 87.55% | 88.10% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 87.46% | 90.24% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 87.31% | 100.00% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 87.30% | 95.00% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 86.99% | 93.10% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 86.94% | 95.89% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 86.29% | 100.00% |
| CHEMBL4071 | P08311 | Cathepsin G | 85.44% | 94.64% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 85.36% | 91.81% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 84.86% | 100.00% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 84.29% | 98.89% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 83.50% | 96.28% |
| CHEMBL2095172 | P14867 | GABA-A receptor; alpha-1/beta-2/gamma-2 | 83.28% | 92.67% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 82.34% | 92.29% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 82.29% | 94.66% |
| CHEMBL3837 | P07711 | Cathepsin L | 82.23% | 96.61% |
| CHEMBL3202 | P48147 | Prolyl endopeptidase | 81.67% | 90.65% |
| CHEMBL6175 | Q9H3R0 | Lysine-specific demethylase 4C | 80.97% | 96.69% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 80.61% | 90.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139588920 |
| LOTUS | LTS0179834 |
| wikiData | Q105216259 |